Arete Wealth Advisors’s Boston Scientific BSX Stock Holding History

Arete Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,162	Closed	-$301K	–	375
2025 Q4	$301K	Sell	3,162 -69	-2%	-$6.76K	0.02%	599
2025 Q3	$315K	Sell	3,231 -2,195	-40%	-$227K	0.02%	582
2025 Q2	$583K	Buy	5,426 +142	+3%	+$14.4K	0.04%	368
2025 Q1	$533K	Buy	5,284 +1,836	+53%	+$185K	0.04%	369
2024 Q4	$308K	Buy	+3,448	New	+$304K	0.02%	546
2024 Q3	–	Sell	-2,601	Closed	-$200K	–	727
2024 Q2	$200K	Buy	+2,601	New	+$190K	0.02%	663

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Arete Wealth Advisors's BSX Position: Q1 2026 in Review

Arete Wealth Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,162 shares — an estimated $301K sold.

Arete Wealth Advisors first reported a position in BSX in Q2 2024 and held it in 6 quarters. The position peaked at $583K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Arete Wealth Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Arete Wealth Advisors sold 3,162 Boston Scientific shares in Q1 2026, an estimated $301K.
Arete Wealth Advisors first reported a position in Boston Scientific in Q2 2024 and held it in 6 quarters.
Arete Wealth Advisors's Boston Scientific position peaked at $583K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.